Bluecrest Wellness Cancer screening

Female Cancer Risk (over 40s)

A wide cancer-risk and general health screen for women over 40, covering bowel, cervical and stomach cancer risk markers alongside liver, kidney, thyroid and immune function.

  • Doctor reviewed
  • Female
Sample
Mixed
Collection
Venous draw at local venue plus at-home self-collection kit(s)
Results in
3–8 days
Biomarkers
35
Doctor reviewed
Yes
Tests for
  • Blood Health Markers
  • Bone Health, Energy & Muscles
  • Bowel Cancer Risk (qFIT test)
  • Cervical Cancer Risk (HPV test)
  • Cholesterol & Advanced Diabetes
  • Essential Proteins and Iron
  • Immune System
  • Kidney Function
  • Liver Function
  • Lung Function Check for COPD
  • Stomach Cancer Risk (H Pylori)
  • Thyroid Function
  • +1 more

Test specifications

Provider
Bluecrest Wellness
Sample type
mixed
Collection method
venous draw at local venue plus at-home self-collection kit(s)
Turnaround time
3–8 days
Biomarkers tested
35
At-home test
No
Doctor reviewed
Yes
Gender focus
Female

What's tested

13 biomarkers as listed by Bluecrest Wellness, of 35 in total.

  • Blood Health Markers
  • Bone Health, Energy & Muscles
  • Bowel Cancer Risk (qFIT test)
  • Cervical Cancer Risk (HPV test)
  • Cholesterol & Advanced Diabetes
  • Essential Proteins and Iron
  • Immune System
  • Kidney Function
  • Liver Function
  • Lung Function Check for COPD
  • Stomach Cancer Risk (H Pylori)
  • Thyroid Function
  • Urinalysis

About this test

The Female Cancer Risk package is aimed at women aged 40 and over and combines tests that may flag signs associated with bowel, cervical and stomach cancer, specifically a qFIT bowel cancer risk test, an HPV cervical cancer risk test and an H. pylori stomach cancer risk test, alongside a wider set of 35 biomarkers covering blood health, bone health, cholesterol, kidney and liver function, lung function, thyroid function and urinalysis. Bluecrest is explicit that none of these tests are diagnostic on their own; any abnormal result would need further investigation by a GP or other healthcare provider.

At 35 biomarkers, this places in the 89th percentile for clinical depth among the cancer screening tests we track, one of the broader packages in that category. There are no directly comparable packages in our data to benchmark the £319 price against, so we cannot say whether it is expensive or good value relative to peers.

Results and follow-up score well here relative to most of Bluecrest's range, because this package includes a doctor review and a private GP consultation by phone or webcam to talk through your results, plus access to specialist cancer nursing support through Perci Health if any cancer-risk result comes back amber or red.

Who is it for?

This suits women aged 40 and over who want a wide screen across several cancer-risk areas alongside a general health check, and who value having a GP consultation to talk through the results rather than reading a report alone. Bluecrest does not recommend this package under age 40, citing a higher chance of false positive and false negative results in younger women. If your main interest is heart disease and stroke risk specifically, the Female Cancer + Complete version adds an ECG, peripheral arterial disease check and Lipoprotein(a) test on top, for £519 total.

How it works

Collection is mixed: a venous blood draw is taken at a local Bluecrest venue, alongside at-home self-collection kits for tests such as the bowel and cervical cancer risk markers. Once your samples are processed, Bluecrest states results are returned in around 3 to 8 days. Results are reviewed by a doctor, and you get a private consultation by phone or webcam to discuss them; if any cancer-risk result is amber or red, you also get access to specialist cancer nursing support through Perci Health at no extra cost.

Pros & cons

Pros

  • Includes a doctor review and a private GP consultation by phone or webcam, unlike most of Bluecrest's individual tests.
  • Covers 35 biomarkers across cancer-risk and general health in one package.
  • Access to specialist cancer nursing support through Perci Health if a cancer-risk result comes back amber or red.
  • Combines at-home self-collection kits with a venous blood draw rather than requiring multiple separate bookings.

Cons

  • Not recommended for women under 40 because of a higher risk of false positive and false negative results.
  • No comparable package in our data to check whether £319 is good value.
  • None of the cancer-risk tests are diagnostic on their own; abnormal results need further GP investigation.

Our editorial score

Compare Health Test Score Women's cancer-risk screen adding an HPV cervical test
Editorial confidence: 10.0/10

This £319 package for women over 40 combines cancer-risk markers, including bowel (qFIT), cervical (HPV) and stomach (H. pylori), with a wider health check covering liver, kidney, thyroid and immune function across 35 biomarkers. Bluecrest has no comparable package in our data to benchmark the price against, but unlike most of Bluecrest's individual tests, results here are reviewed by a doctor and include a private consultation.

Score breakdown

  • Clarity and documentation 8.0/10

    The listing publishes a detailed description, some of the biomarkers by name, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.

  • Clinical depth 9.9/10

    35 biomarkers, placing it in the 89th percentile of cancer screening tests we track.

  • Collection convenience 7.0/10

    A finger-prick sample you take at home; with a venous or clinic option as well; results in around 8 days, slower than similar tests.

  • Results and follow-up 7.0/10

    Results are reviewed by a doctor; the provider does not describe the report format.

  • Trust signals 9.5/10

    Trustpilot 4.7 from 6,787 reviews; accredited lab (UKAS ISO 15189 own lab); CQC registered; trading 14+ years.

  • Value for money 6.0/10

    £319.00; no comparable tests to benchmark against yet.

Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.

More in Cancer screening

View all →
Selph

qFIT Bowel Cancer Screening Test

Priced close to the FIT test group median

A stool test using the qFIT method to measure blood in a stool sample, giving a numerical result rather than a simple positive or negative. Suited to adults wanting to check a common early indicator of possible bowel cancer risk.

  • At-home test
8.1 / 10
£59.00
Full review →